|
|
|
|
LEADER |
02662cam a2200553 a 4500 |
001 |
693324824 |
003 |
OCoLC |
005 |
20110624113416.0 |
006 |
m d f |
007 |
cr m|||||||||| |
008 |
101216s2010 dcua ob f000 0 eng c |
040 |
|
|
|a DOS
|b eng
|c DOS
|d GPO
|d MvI
|
042 |
|
|
|a pcc
|
043 |
|
|
|a n-us---
|
049 |
|
|
|a COM7
|
050 |
|
4 |
|a QH332
|b .U545 2010eb online
|
074 |
|
|
|a 0851-J-12 (online)
|
086 |
0 |
|
|a PR 44.8:B 52/ET 3
|
110 |
1 |
|
|a United States.
|b Presidential Commission for the Study of Bioethical Issues.
|
245 |
1 |
0 |
|a New directions
|h [electronic resource] :
|b the ethics of synthetic biology and emerging technologies /
|c Presidential Commission for the Study of Bioethical Issues.
|
246 |
1 |
|
|a Ethics of synthetic biology and emerging technologies.
|
264 |
|
1 |
|a Washington, D.C. :
|b Presidential Commission for the Study of Bioethical Issues,
|c [2010]
|
300 |
|
|
|a 1 online resource (178 pages) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent.
|
337 |
|
|
|a computer
|b c
|2 rdamedia.
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier.
|
500 |
|
|
|a "December 2010."
|
500 |
|
|
|a GPO Cataloging Record Distribution Program (CRDP).
|
504 |
|
|
|a Includes bibliographical references (pages 167-174).
|
588 |
|
|
|a Title from PDF title page (Presidential Commission for the Study of Bioethical Issues, viewed December 16, 2010).
|
650 |
|
0 |
|a Synthetic biology
|x Government policy
|z United States.
|
650 |
|
0 |
|a Bioengineering
|x Government policy
|z United States.
|
610 |
2 |
0 |
|a J. Craig Venter Institute.
|
650 |
|
0 |
|a Bioethics
|z United States.
|
650 |
|
0 |
|a Synthetic biology
|x Moral and ethical aspects
|z United States.
|
650 |
|
0 |
|a Bioengineering
|x Moral and ethical aspects.
|
776 |
0 |
8 |
|i Print version:
|a United States. Presidential Commission for the Study of Bioethical Issues.
|w (DLC) 2010532524
|w (OCoLC)694081212.
|
856 |
4 |
0 |
|u https://purl.fdlp.gov/GPO/gpo9019
|
907 |
|
|
|a .b33364722
|b cug
|c -
|d 110718
|e 230228
|
998 |
|
|
|a cug
|b 210212
|c m
|d a
|e -
|f eng
|g dcu
|h 0
|i 1
|
948 |
|
|
|a MARCIVE Comp, in 2022.12
|
948 |
|
|
|a MARCIVE Over, 03/2021
|
948 |
|
|
|a MARCIVE August, 2017
|
948 |
|
|
|a MARCIVE extract Aug 5, 2017
|
995 |
|
|
|a Loaded with m2btab.ltiac in 2022.12
|
995 |
|
|
|a Loaded with m2btab.ltiac in 2021.03
|
995 |
|
|
|a Loaded with m2btab.b in 2021.02
|
995 |
|
|
|a Loaded with m2btab.ltiac in 2017.08
|
989 |
|
|
|a PR 44.8:B 52/ET 3
|d cuege
|e - -
|f - -
|g j
|h 0
|i 0
|j 216
|k 110718
|l $0.00
|m
|n - -
|o -
|p 0
|q 0
|t 0
|x 0
|w US Gov Docs
|1 .i65922724
|u http://purl.fdlp.gov/GPO/gpo9019
|u http://www.bioethics.gov/documents/synthetic-biology/PCSBI-Synthetic-Biology-Report-12.16.10.pdf
|